Newsletter - Alzheimer Europe July-August 2023 newsletter https://alzheimereurope.newsweaver.com/Newsletter/ en-us 05 Sep 2023 03:04:47 CEST 05 Sep 2023 03:04:47 CEST https://alzheimereurope.newsweaver.com/Newsletter/rss.xml Newsweaver info@alzheimer-europe.org () support@newsweaver.ie (Newsweaver) 60 true Welcome https://alzheimereurope.newsweaver.com/Newsletter/1koe31tida0?lang=en?rss=true Alzheimer Europe’s July-August 2023 newsletter [ https://alzheimereurope.newsweaver.com/Newsletter/8oaodpdfajs/external ] brings you the latest news on developments in the dementia field, across Europe and beyond. Summaries of a few of our top stories appear below. Our monthly newsletter reaches thousands of people with an interest in the field, from across Europe and beyond. We are always happy to receive feedback, or suggestions regarding news items to share. [ https://alzheimereurope.newsweaver.com/Newsletter/8oaodpdfajs/external ] 05 Jun 2023 12:00:00 CEST 5bc0b8a6ed1103d8d82dd382eac57fed Feature Article <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/2b/92a8976269fb1f449eddd2.jpg" style="margin: 5px;" width="150" height="100" hspace="5" vspace="5" alt="">Alzheimer Europe’s<strong> <strong><a href="https://alzheimereurope.newsweaver.com/Newsletter/8oaodpdfajs/external" target="_blank" rel="noreferrer noopener">July-August 2023 newsletter</a> </strong></strong>brings you the latest news on developments in the dementia field, across Europe and beyond.</p> <p style="text-align: justify;">Summaries of a few of our top stories appear below.</p> <p style="text-align: justify;">Our monthly newsletter reaches thousands of people with an interest in the field, from across Europe and beyond. We are always happy to receive feedback, or suggestions regarding news items to share.</p> <p style="text-align: justify;"> </p> <p class="centered-only" style="text-align: center;"><a href="https://alzheimereurope.newsweaver.com/Newsletter/8oaodpdfajs/external" target="_blank" rel="noreferrer noopener"><img align="middle" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/33/9a2b2c753c2ca4ee114ecc.jpg" style="margin: 0px;" width="200" height="48" hspace="0" vspace="0" alt=""></a></p> 6 July: Slovenian Government approves new national dementia strategy until 2030 https://alzheimereurope.newsweaver.com/Newsletter/v2cxsnqcmp0?lang=en?rss=true On 6 July 2023, the Government of the Republic of Slovenia approved the new Strategy for Dementia Management in Slovenia until 2030. This is a significant step and achievement for people with dementia and their carers and it is also an important development for tackling dementia in Slovenia as a whole. The adoption of this new strategy means the implementation of the goals it sets out can begin. 05 Sep 2023 12:00:00 CEST c4a5b316df092dc38c9676bdb99e959c Other Articles <p class="text-align-justify" style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/f1/28b7f058f7009b6b60a80e.jpg" style="margin: 5px;" width="150" height="150" hspace="5" vspace="5" alt="">On 6 July 2023, the Government of the Republic of Slovenia approved the new Strategy for Dementia Management in Slovenia until 2030. This is a significant step and achievement for people with dementia and their carers and it is also an important development for tackling dementia in Slovenia as a whole. The adoption of this new strategy means the implementation of the goals it sets out can begin.</p> <p class="text-align-justify"> </p> https://www.alzheimer-europe.org/news/slovenian-government-approves-new-national-dementia-strategy-until-2030 16-20 July: Alzheimer’s Association International Conference takes place in Amsterdam https://alzheimereurope.newsweaver.com/Newsletter/gxsidko6lpe?lang=en?rss=true Congratulations the organisers of the Alzheimer’s Association International Conference, which took place in Amsterdam from 16-20 July 2023. Several members of the Alzheimer Europe team, myself included, travelled to the event, which brought together a huge number of participants, in an atmosphere of optimism and excitement. 05 Sep 2023 12:00:00 CEST 327195ca1e1742f2bc38e9639f6da800 Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/2e/03ffbcb5244127b389e577.jpg" style="margin: 5px;" width="150" height="150" hspace="5" vspace="5" alt="">Congratulations the organisers of the Alzheimer’s Association International Conference, which took place in Amsterdam from 16-20 July 2023. Several members of the Alzheimer Europe team, myself included, travelled to the event, which brought together a huge number of participants, in an atmosphere of optimism and excitement. </p> https://www.alzheimer-europe.org/news/alzheimer-europe-actively-participates-alzheimers-association-international-conference-aaic 17 July: Lilly presents from donanemab clinical trial results at AAIC https://alzheimereurope.newsweaver.com/Newsletter/li1n5zqtrhc?lang=en?rss=true On 17 July 2023, Eli Lilly and Company presented the full results of its TRAILBLAZER-ALZ2 randomised clinical trial looking at whether the drug donanemab provides clinical benefit in early symptomatic Alzheimer’s disease. Topline results were announced in a company press release earlier in the year (3 May), and the full trial results were shared at AAIC during a featured symposium and simultaneously published in the Journal of the American Medical Association (JAMA). 05 Sep 2023 12:00:00 CEST 55a555da75864ff4eaa2c83f2b6ad7a4 Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/48/3fcdd7983d7891979a4806.png" style="margin: 5px;" width="150" height="119" hspace="5" vspace="5" alt="">On 17 July 2023, Eli Lilly and Company presented the full results of its TRAILBLAZER-ALZ2 randomised clinical trial looking at whether the drug donanemab provides clinical benefit in early symptomatic Alzheimer’s disease. Topline results were announced in a company press release earlier in the year (3 May), and the full trial results were shared at AAIC during a featured symposium and simultaneously published in the Journal of the American Medical Association (JAMA). </p> https://www.alzheimer-europe.org/news/results-lillys-trailblazer-alz2-clinical-trial-donanemab-are-presented-alzheimers-association 26 July: Ten early stage researchers win bursaries for our conference https://alzheimereurope.newsweaver.com/Newsletter/154ohuysiwd?lang=en?rss=true We are delighted to announce the early stage researchers who have been selected by our jury, to benefit from the bursaries provided by the Alzheimer Europe Foundation to attend and present at the 33rd Alzheimer Europe Conference, in Helsinki in October. The selection of the ten bursaries was based on the best average scores each received from the jury members. Each of them was informed about the exciting news on 26 July 2023. 05 Sep 2023 12:00:00 CEST cf4f5e5e1668a5a15a9a1f51ffe7d346 Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/e2/e0511f26463cf51d3d49fe.jpg" style="margin: 5px;" width="150" height="152" hspace="5" vspace="5" alt="Helsinki teaser">We are delighted to announce the early stage researchers who have been selected by our jury, to benefit from the bursaries provided by the Alzheimer Europe Foundation to attend and present at the 33rd Alzheimer Europe Conference, in Helsinki in October. The selection of the ten bursaries was based on the best average scores each received from the jury members. Each of them was informed about the exciting news on 26 July 2023. </p> https://www.alzheimer-europe.org/news/congratulations-ten-early-stage-researchers-who-won-alzheimer-europe-foundation-bursaries 4 September: We’re hiring! https://alzheimereurope.newsweaver.com/Newsletter/1e48ys0vzvs?lang=en?rss=true Alzheimer Europe is looking to fill two new full-time Luxembourg-based positions, on a permanent basis, aPublic Involvement Officer and a Project Officer. Both are full-time, permanent positions, based in Luxembourg. To apply for either of these two positions, please send your CV, together with a cover letter (both documents in English), by 30 September 2023. Please note that, to apply, you must be an EU citizen or have an EU work permit. 05 Sep 2023 12:00:00 CEST d00d6d3961ff816496dea288fd21eed1 Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/71/dce2215724b5b4b272d695.jpg" style="margin: 5px;" width="150" height="150" hspace="5" vspace="5" alt="">Alzheimer Europe is looking to fill two new full-time Luxembourg-based positions, on a permanent basis, aPublic Involvement Officer  and a Project Officer. Both are full-time, permanent positions, based in Luxembourg. To apply for either of these two positions, please send your CV, together with a cover letter (both documents in English), by 30 September 2023. Please note that, to apply, you must be an EU citizen or have an EU work permit.</p> https://www.alzheimer-europe.org/news/we-are-recruiting-two-new-full-time-permanent-positions-public-involvement-officer-and-project